Technology Transfer is one of the key elements of the drug development process that requires a simple and efficient process through logistics and integration of transfer activities for scale-up, optimization, manufacturing, packaging, and commercial launch of the product. This recorded seminar will present the "Ten Principles of the Technology Transfer Process" that are proven to assure the success and efficiency of the process.
Approximate Course Duration: 60 minutes (this is a self-paced course)
*NOTE* You will have 5 calendar days to access and complete this course from time of purchase.
ISPE CEUs: .10 ISPE CEUs will be awarded upon successful completion of grading requirements
Adnan Sabir is a Principal Consultant of Pharma Consulting Services providing consultation in formulation/process development and technology transfer of pharmaceuticals. Prior to this he was an Associate Director in Process Development at Watson Laboratories Inc., California. He received two Master of Science degrees in pharmaceutical technology from Nagpur University, India, and industrial pharmacy from the Long Island University (LIU), New York. From 1985 to 1992, Sabir served as a Scientist holding various positions in Solvay Pharmaceuticals, where he worked on the development of various solid, liquid, and semi-solid dosages. In 1992, he joined GlaxoSmithKline (then was Glaxo) as a Senior Scientist in Clinical Supplies and progressed to the position of Principal Scientist, Technology Transfer. Prior to joining Watson in 2004, he was Manager at Celltech in Rochester, NY. At Watson Sabir is responsible for manufacturing of registration batches, scale-up, and technology transfer of OC products to various manufacturing sites. He has been an active member and a strong supporter of AAPS since 1985. He served as the VSP, a member of Process Development Focus Group, and has delivered lectures on Career Opportunities in Pharma Industry to the graduates at several universities. Sabir is also an active member of ISPE organization currently focusing on PAT and QbR initiatives. He organized and chaired several scientific symposia at GSK. He chaired the Pharmaceutical Discussion Group in 1997 in GSK. Sabir is a Fellow of AAPS and the American Association of Indian Pharmaceutical Scientists (AAiPS).
Discounted member price:
You could save